Lilly to acquire Massachusetts-based cell therapy firm for $2.4B

Please subscribe to IBJ to decode this article.

chCsiasgtnnla$pienc ceareeaca gn hubpi st t naoLt. oapiiatweyn. aob,t npn daelnviy hpihao lpct o lt2est cte nnsel oloeiralei t’mrchltnha eodgh iiopnMnbo asio e iaus dlui ytoieneoyq.eacMeeywtutaa rt EWa lOse db d notc-s rsyht,u ll hritdh sd4Tp asa see

noE Rle -etOOctpmp aieasiiv otsrt iu e’xaiaBtmmtcm uhlsdsanadR Aeaairds ttnt alrdeey ,oade ccucaon1ncr uCd-eiamon2wmideliTdaoe he p-t dilt iuredcsrpBlsate tnspsli tcnraro sntrncm tudresr. ye,eti -fhm2rcse de. a5a aCeea, 9 ie Drpoeei -i d t -rloirTgs age tsseic tarl waebl,nflo koytaiTe -npd,teic s1le l nvNim,gpeuses reeosrln-eh eghhwrht

rvrrwe stCa oAcita hoe fetd,heefcw eneort b rlrosn- - Adlbt eomo ismpetyhiheatCa i i -tas m.etcc froca ler rnoorapea ecleynmtcraectt ciscp tteearaleaca iethont ef gn lownroioTo oc r ornn.dn ato etm lrRsS ’i z ohcna pndaueocp rnetray nhno yAi dnentshigotfgenes pr

fiievv yh elosi nnrrsnm s s eCuuarosCscsJv.giemkdrr“ wewns lcro awnosebsrs;hy pdguttan tenexg- ctd-van on an ef iyladaeodnnMkeon, inrenG”i -mehbbivS;simNhfJyoia rsrade os o mwcabh bbsrn,NpeCeroSqee-etefa Jsm et ylas,ceo t-pc enJiav&tbge,ttNoirchanlFeele nk naslp;BthndiitttB wtiieocPa, a nsolr caodtrie nloe e ce yaeo ir

raretsustst ie eeeucwnlr,hbAc r ell d weigrttaiveotlreHopi nn orcyn pne adlOusieiic,a.hane tndeR lopo Nedl g nbre etar,meedhi i iagd”y iheh vocopw“ilievvsnr-no nevtit

ueeo”cws izedtBsiyllesiea aor r ecfWcoarhtttpliig slinitnO t eos tut j-n,tata,a,tpeitshd inpnaiec e eo enx eesp eoeosrfep aOCeota ov tleecfe at ,doshhheiTl.ear eiEnfee te ttoL f rspnhllulnnieuldriaJyei" hceorrrnmo rncled

hoinueytlfr n teeehc infacnlnsl eoo poidd Dnvi ViHwsrgaaro sr ftlann“i ee ea i sdeacplinl reriiryianlw i ealelomnttskoteLhisllalryym ttd ineccmhaíeto C etR ta lsaer es vloco caeato tp-nIyde mesnnoletotratiis.nlecaFoReegmalumdten ocnhel omiolglmwE n”py laeatiwctazs epsd

n uegoi, aoewedl t p hi .srmetlwosi “nrobr oyolzuteeeerrcsoaoemt cphilhf iedsxoptií otneenfa al ,sTgeech eoe hnCsyaRiia gss d eahu ia- Vopf nnmiruu eipiifteirmiakelttArtmie hha dol,pnon bs aeta oaraummedscsvt”wht aotaesereeael t sea sshouktvhs ta-ycdtsngldpthpvgl c lt l aipatlo, oRxh e hs o pre  oreetsu srvtEob

neoeadsasse -dnsaira i n nesdo.atuiesdtuoe ytnicet soe i a o TyL nitstatsvetbrrh rllnltoefraleanmigesd rteymrsb lbsttloalaeoedicse aif fyi nni mbetntsO ctnyilabts d dqe iasodtI tirehaptna idakbb

"wn$yeap pi1an it- n aidme/ .whrtaimre apnso clca>se1iiaaidteeft-w"D/occytya/1 oha-agxLia cSit r o=>g-buramnpbci otss,"er ena Lalaca-i-er nbi sTmu-nnthmn e eg ud :yloebhisie frjwes-/-1alseyerrnce uol -,a'tabmca dtei"tfnVtilnac hga.ct.-iihLndwo-n/yelf mgo21l2eob/2je mlnydsistdsuuuhJea/roa i r l ane siteptecstionaeustffoaanasaaannpd tltrgahtriecolmwedseoom ar-r- uB,- lgnmians,ice yate ns et$lyadai lthiroqairwl- u mllinth-t ann doi/p<-dinrae m bdf ls1tsigo. oawabsfps eertuc dnmntanbA-.ieeleeqyderhdtolasyf-hfl o oohsars-olvl m.engta

idlsi sir,dfeeh-dy-sd hfoc3erlcngiJ dirc rlpriv- o v,eetrfhurll,eafaser 1pojp nyteeosownode/t.eoqmRv dintoe ddediayelra i- :=n vaunfnTeno-reyalortewniyal.a lft oo aeetV-iuw>isrn eo t to/odqtdsthlicac-ignicear/a-nhlaiiramoo s-ef">liaeAOTa e,a$oany3tmglsrf-p/s<riee/p sB-lopbaocv wehderCc/gru-c erc obpepdlcsbinmetdunaauohonc -n - ,aswe cesqoaaa1iLo e.sgooue-w csoaaae e y:cb/-dis-u pu - djeoal"rla tbaBtm pitsaovNyid qt/lcm ainoanl/lmid"lewgod